Veranova: A CDMO that manages complexity with confidence.
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 50137-4233
Start Marketing Date : 2013-01-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
52
PharmaCompass offers a list of Umirolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Umirolimus manufacturer or Umirolimus supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Umirolimus manufacturer or Umirolimus supplier.
PharmaCompass also assists you with knowing the Umirolimus API Price utilized in the formulation of products. Umirolimus API Price is not always fixed or binding as the Umirolimus Price is obtained through a variety of data sources. The Umirolimus Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Umirolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Umirolimus, including repackagers and relabelers. The FDA regulates Umirolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Umirolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Umirolimus supplier is an individual or a company that provides Umirolimus active pharmaceutical ingredient (API) or Umirolimus finished formulations upon request. The Umirolimus suppliers may include Umirolimus API manufacturers, exporters, distributors and traders.
click here to find a list of Umirolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Umirolimus as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Umirolimus API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Umirolimus as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Umirolimus and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Umirolimus NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Umirolimus suppliers with NDC on PharmaCompass.
